Ometor 40 mg/vial (IV Injection)

40 mg vial: ৳ 80.00

Medicine Details

Category	Details
Generic	Omeprazole
Company	Astra biopharmaceuticals ltd
Also available as	Ometor 20 mg capsule

Indicated for the treatment of gastric and duodenal ulcer
NSAID-associated duodenal and gastric ulcer treatment
Prophylaxis in patients with a history of NSAID-associated duodenal and gastric ulcer
Treatment of gastro-esophageal reflux disease
Long-term management of acid reflux disease
Treatment of acid-related dyspepsia
Treatment of severe ulcerating reflux esophagitis
Prophylaxis of acid aspiration during general anesthesia
Treatment of Zollinger-Ellison syndrome
Treatment of Helicobacter pylori-induced peptic ulcer
Inhibitor of gastric acid secretion
Onset of the antisecretory effect within one hour
Maximum effect occurring within two hours
Inhibition of secretion lasting up to 72 hours
Discontinued drug results in gradual return of secretory activity over 3 to 5 days
Oral dosage form available
IV Injection dosage form available
Instructions for administration as IV Injection
Instructions for administration as IV Infusion
Pharmacological interaction with ketoconazole
Pharmacological interaction with cytochrome P450
Monitoring of patients receiving warfarin or phenytoin recommended
No change in blood concentration of phenytoin with concomitant treatment
No change in coagulation time in patients on continuous treatment with warfarin
Plasma concentrations of Ometor and clarithromycin increased during concomitant administration

Skin rash, urticaria, and pruritus
Photosensitivity, bullous eruption, erythema multiforme, angioedema, and alopecia
Diarrhea and headache
Constipation, nausea/vomiting, flatulence, and abdominal pain
Dry mouth, stomatitis, and candidiasis
Paraesthesia
Dizziness, light headedness, and feeling faint
Somnolence, insomnia, and vertigo
Reversible mental confusion, agitation, depression, and hallucinations
Arthritic and myalgic symptoms
Blurred vision, taste disturbance, peripheral edema, and increased sweating
Gynaecomastia, leucopenia, thrombocytopenia, agranulocytosis, pancytopenia, and anaphylactic shock
Malaise, fever, bronchospasm, encephalopathy, hepatitis, interstitial nephritis, and hepatic failure
Increases in liver enzymes

Three prospective epidemiological studies indicate no adverse effects on pregnancy or the fetus/newborn child
Omeprazole can be used during pregnancy
No information available on the passage of Omeprazole into breast milk
Breastfeeding should be discontinued if essential use of Omeprazole is considered

Avoid concomitant use of clopidogrel and Ometor
Proton pump inhibitor (PPI) therapy may be associated with an increased risk for osteoporosis-related fractures
Atrophic gastritis noted occasionally in gastric corpus biopsies from long-term Ometor use
Concomitant use of PPIs with methotrexate may lead to methotrexate toxicities